Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells
Oncology Reports · 2024
DOI: 10.3892/or.2024.8768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Yuki Morino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan. Hauptthemen laut MEDLINE: Arsenic Trioxide, Leukemia, Promyelocytic, Acute, Cell Proliferation, Arsenicals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan.
Zitieren
APA
Morino, Y., Sugiyama, H., Yamane, K., Kikuchi, M., Yamanaka, T., Honda, K., & Monzen, S. (2024). Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells. Oncology Reports. https://doi.org/10.3892/or.2024.8768
Vancouver
Morino Y, Sugiyama H, Yamane K, Kikuchi M, Yamanaka T, Honda K, et al. Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells. Oncology Reports. 2024. doi:10.3892/or.2024.8768
BibTeX
@article{Morino2024,
author = {Morino, Yuki and Sugiyama, Hikoto and Yamane, Kazuma and Kikuchi, Megumi and Yamanaka, Takamasa and Honda, Kazuma and Monzen, Satoru},
title = {Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8768}
}
EUVIMED